Comparing the effects of isotretinoin 20 mg versus azithromycin 500 mg in the management of acne vulgaris: a randomized clinical trial
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16615 ↗At a glance
Randomisierte kontrollierte Studie in International Journal of Dermatology, 2023. Written by Uzma Dost Muhammad Rajar and 4 co-authors. Institution: Dermatology Department, Isra University, Hyderabad, Pakistan. Major MEDLINE topics: Acne Vulgaris, Dermatologic Agents. 21 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Dermatology Department, Isra University, Hyderabad, Pakistan.
- Dermatology, Combined Military Hospital, Rawalpindi, Pakistan.
- Department of Pathology, People's University of Medical and Health Sciences for Women (PUMHSw), Shaheed, Benazirabad, Pakistan.
- Isra University, Hyderabad, Pakistan.
- Kiran Hospital, Karachi, Pakistan.
ORCID profiles: Uzma Dost Muhammad Rajar
Cite
APA
Rajar, U. D. M., Mashhood, A. A., Fahim, A., Kazi, N., & Hanif, M. (2023). Comparing the effects of isotretinoin 20 mg versus azithromycin 500 mg in the management of acne vulgaris: a randomized clinical trial. International Journal of Dermatology. https://doi.org/10.1111/ijd.16615
Vancouver
Rajar UDM, Mashhood AA, Fahim A, Kazi N, Hanif M. Comparing the effects of isotretinoin 20 mg versus azithromycin 500 mg in the management of acne vulgaris: a randomized clinical trial. International Journal of Dermatology. 2023. doi:10.1111/ijd.16615
BibTeX
@article{Rajar2023,
author = {Rajar, Uzma Dost Muhammad and Mashhood, Asher Ahmed and Fahim, Amin and Kazi, Navaid and Hanif, Muhammad},
title = {Comparing the effects of isotretinoin 20 mg versus azithromycin 500 mg in the management of acne vulgaris: a randomized clinical trial},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16615}
}
EUVIMED